Results 311 to 320 of about 163,967 (338)

Malignant Neoplasms Occurring After Cardiac Transplantation

JAMA: The Journal of the American Medical Association, 1983
Fifty-seven cardiac transplants in 53 patients have been performed; 30 survived for at least three months. Malignant neoplasms developed in three (10%) of these patients. This incidence is more than double that in recipients of donor kidneys at our institution. Kaposi's sarcoma developed in three patients in the combined groups and accounted for 30% of
R P, Lanza, D K, Cooper, M J, Cassidy, C N, Barnard   +3 more
openaire   +3 more sources

[Malignant neoplasms and kidney transplantation].

Der Urologe. Ausg. A, 2010
Together with cardiovascular disorders and metabolic changes, malignant diseases are considered as great challenges in clinical transplantation. As far as long-term function of transplanted organs is concerned, an impact of malignancies is obvious. However, it is important to distinguish between neoplastic disease originating from preexisting lesions ...
H, Heynemann, A, Hamza, S, Wagner, R, Hoda, A, Schumann, P, Fornara   +5 more
openaire   +1 more source

[Neoplasms in kidney transplant patients].

Actas urologicas espanolas, 1994
Our service performed a total of 619 kidney transplants between February 1980 and March 1993. Among them, 41 new neoplasias (6.6%) were diagnosed. Most frequent tumour was epithelioma (25) with a presentation age lower than in the normal population.
J M, Martínez Jabaloyas, J L, Ruiz Cerda, J M, Osca, J L, Perales Ruiz, R, Alfonso Gil, L, Pallardo, J F, Jiménez Cruz   +6 more
openaire   +1 more source

[Neoplasm prevalence in renal transplantation].

Archivos espanoles de urologia, 1997
To analyze the prevalence of neoplasms in renal transplant patients and the relative risk for each tumor type according to the immunosuppression regimen.609 renal transplants were reviewed. The risk index was determined by the ratio of the cases observed and predicted.Tumor prevalence was 4.9% (30/609); 6.3% (25/393) were males and 2.3% (5/216) were ...
V, Gómez dos Santos, F J, Burgos Revilla, J, Pascual Santos, L, Orofino Ascunce, G, Fernández-Juárez, L, Crespo Martínez, L, Clemente Ramos, C, Carrera Puerta, R, Marcen Letosa, A, Escudero Barrilero, J, Ortuño Mirete   +10 more
openaire   +1 more source

[Malignant neoplasms and kidney transplantation].

Actas urologicas espanolas, 1995
In 661 renal transplantations, 2 potentially migrated tumours (0.38%), 5 preexisting neoplasias (0.76%), and 31 "de novo" tumours were seen in 29 patients (4.4&). Although of very low incidence, the likelihood of tumour migration from elderly donors, given the circumstances surrounding removal, offers a high risk.
N, Serrallach, L L, Riera, E, Franco, F, Aguiló, J, Muñoz, M A, López-Costea, N, Camps, J, Serra, C, González, A M, Castelao   +9 more
openaire   +1 more source

[Neoplasms following kidney transplantation].

Khirurgiia, 1991
The incidence, predisposing factors, localization, evolution and outcome of neoplasms following kidney transplantation were studied in two groups of patients--120 and 146 patients for an observation period from 1 to 16 years. In patients with adequate renal function who received immunosuppressive treatment for more than one year (accordingly 78 and 88 ...
openaire   +1 more source

Transplantable Mouse Neoplasm Control by Neutron Capture Therapy

Nature, 1967
AFTER several years of effort based on the application of the principles of neutron capture therapy, we have empirically evolved a procedure which now can be added to the few effective treatments for established invasive transplantable neoplasms of animals.
L E, Farr, T, Konikowski
openaire   +2 more sources

Second Malignant Neoplasms following Hematopoietic Stem Cell Transplantation

International Journal of Hematology, 2004
Hematopoietic stem cell transplantation is being successfully used to treat a variety of malignant and nonmalignant disorders. This therapy has resulted in an increasing number of survivors who are at risk for adverse long-term outcomes, including the development of second and subsequent malignant neoplasms.
Debra L, Friedman, Wendy, Leisenring, Jeffrey L, Schwartz, H Joachim, Deeg   +3 more
openaire   +2 more sources

[Malignant neoplasms in kidney transplant recipients].

Archivos espanoles de urologia, 1996
This study is a retrospective analysis of malignant tumors in renal transplant recipients. A review of the pertinent literature allowed us to develop a protocol for early diagnosis and treatment of tumors arising in this group of patients.171 renal transplants have been performed over a period of 4 years.
G, Escribano Patiño, E, Lledó Garciía, I, Moncada Iribarren, R, Durán Merino, J, Jara Rascón, A, Palacio España, F, González Chamorro, E, Rodríguez Fernández, C, Hernández Fernández   +8 more
openaire   +1 more source

Cutaneous neoplasms in renal transplant recipients.

European journal of dermatology : EJD, 2003
Cutaneous neoplasms are much more common in renal transplant recipients than in the general population, and are the most common malignancies in these patients. This is the case with basal cell carcinoma, and even more so with squamous cell carcinoma. Many risk factors for development of such malignancies are similar to those in the general population ...
Jeffrey Rand, Rubel, Edgar Louis, Milford, Reza, Abdi   +2 more
openaire   +1 more source